LATVIJAS JURAS MEDICINAS CENTRSLATVIJAS JURAS MEDICINAS CENTRSLATVIJAS JURAS MEDICINAS CENTRS

LATVIJAS JURAS MEDICINAS CENTRS

No trades
See on Supercharts
Market capitalization
‪5.60 M‬EUR
−0.00EUR
‪−14.16 K‬EUR
‪9.84 M‬EUR
Beta (1Y)
0.08

About LATVIJAS JURAS MEDICINAS CENTRS

CEO
Janis Birks
Website
Headquarters
Riga
Founded
1944
ISIN
LV0000100741
FIGI
BBG000F4DQR3
Latvijas Juras medicinas centrs AS engages in the provision and management of health care services. It offers diagnostic, dentistry, rehabilitation, day surgery, and laboratory services, vaccinations, health care procedures, and specialist consultations. The company was founded in 1944 and is headquartered in Riga, Latvia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LJM1R is 7.00 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXRSE exchange LATVIJAS JURAS MEDICINAS CENTRS stocks are traded under the ticker LJM1R.
LJM1R stock is 0% volatile and has beta coefficient of 0.08. Check out the list of the most volatile stocks — is LATVIJAS JURAS MEDICINAS CENTRS there?
Yes, you can track LATVIJAS JURAS MEDICINAS CENTRS financials in yearly and quarterly reports right on TradingView.
LJM1R stock has fallen by 22.22% compared to the previous week, the month change is a 30.00% fall, over the last year LATVIJAS JURAS MEDICINAS CENTRS has showed a 34.58% decrease.
LJM1R net income for the last quarter is ‪−98.65 K‬ EUR, while the quarter before that showed ‪284.38 K‬ EUR of net income which accounts for −134.69% change. Track more LATVIJAS JURAS MEDICINAS CENTRS financial stats to get the full picture.
Today LATVIJAS JURAS MEDICINAS CENTRS has the market capitalization of ‪5.60 M‬, it has decreased by 7.89% over the last week.
Yes, LJM1R dividends are paid annually. The last dividend per share was 0.10 EUR. As of today, Dividend Yield (TTM)% is 1.43%. Tracking LATVIJAS JURAS MEDICINAS CENTRS dividends might help you take more informed decisions.
Like other stocks, LJM1R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LATVIJAS JURAS MEDICINAS CENTRS stock right from TradingView charts — choose your broker and connect to your account.
LJM1R reached its all-time high on Apr 7, 2022 with the price of 19.90 EUR, and its all-time low was 1.25 EUR and was reached on Aug 18, 2009.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LATVIJAS JURAS MEDICINAS CENTRS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LATVIJAS JURAS MEDICINAS CENTRS stock shows the strong sell signal. See more of LATVIJAS JURAS MEDICINAS CENTRS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LATVIJAS JURAS MEDICINAS CENTRS EBITDA is ‪301.02 K‬ EUR, and current EBITDA margin is 3.06%. See more stats in LATVIJAS JURAS MEDICINAS CENTRS financial statements.